75 results
Keyword Blenrep Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Kyprolis
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015,
, 
, Revision: 20, Authorised, Last updated: 15/06/2022
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka)
lenalidomide hydrochloride monohydrate, Multiple Myeloma; Lymphoma, Follicular
Date of authorisation: 11/02/2021,
, Revision: 3, Authorised, Last updated: 17/12/2021
-
List item
National expert: Christian Gisselbrecht, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 41.61 KB | PDF
- Curriculum Vitae - 53.78 KB | PDF
of Belantamab Mafodotin (Blenrep) for the Treatment of Adult … -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 September 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 11/09/2023 to 14/09/2023, Last updated: 14/09/20239 2.3.4. Blenrep - belantamab mafodotin … -
List item
List of medicines under additional monitoring (updated)
Last updated: 26/09/2023 -
List item
PRIME: priority medicines (updated)
Last updated: 02/10/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 June 2023
European Medicines Agency, Amsterdam, the Netherlands, from 05/06/2023 to 08/06/2023, Last updated: 04/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 13/03/2023 to 16/03/2023, Last updated: 22/06/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28-31 August 2023
European Medicines Agency, Amsterdam, the Netherlands, from 28/08/2023 to 31/08/2023, Last updated: 28/08/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2023 to 14/04/2023, Last updated: 07/07/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 25/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-26 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 24/04/2023 to 26/04/2023, Last updated: 07/07/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 27/03/2023 to 30/03/2023, Last updated: 22/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 11/09/20239 2.3.4. Blenrep - belantamab mafodotin …
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 August - 1 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 29/08/2022 to 01/09/2022, Last updated: 02/09/2022 -
List item
Seventh industry stakeholder platform on research and development support
Online, 23/11/2021, Last updated: 17/03/2022 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Sixth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines
Online, 30/06/2021, Last updated: 24/09/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 12/08/2022 -
List item
News: Human medicines: highlights of 2020
Last updated: 21/01/2021Tetra MenQuadfi Mvabea Supemtek Vaxchora Zabdeno Cancer Aybintio Ayvakyt Blenrep Cabazitaxel Accord Daurismo Enhertu Equidacent Lenalidomide … loss of movement. Cancer Blenrep to treat adult patients with … -
List item
Committee for Orphan Medicinal Products (COMP): 8-10 September 2020
Virtual meeting, from 08/09/2020 to 10/09/2020, Last updated: 12/11/2020 -
List item
Leaflets
Last updated: 23/09/2016 -
List item
News: Annual report 2020 published
Last updated: 14/06/2021